To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
Objective: To compare two oral treatments: Ofloxacin + Metronidazole, and Azitromycin
+Metronidazole in outpatients with Pelvic Inflammatory Disease.
Materials and Methods: Two hundred patients divided to two groups( A , B). Group A (treated
by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine
1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy